| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.5056/JNM16203 |
| P8608 | Fatcat ID | release_bvkuwekshbbp7pyyzh4aboebie |
| P932 | PMC publication ID | 5503283 |
| P698 | PubMed publication ID | 28551943 |
| P50 | author | Jakub Fichna | Q22115026 |
| Jakub Włodarczyk | Q55276377 | ||
| P2093 | author name string | Martin Storr | |
| Adam Fabisiak | |||
| Natalia Fabisiak | |||
| P2860 | cites work | Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors | Q24310198 |
| Gut microbiota role in irritable bowel syndrome: New therapeutic strategies | Q26768550 | ||
| Mast Cells and Irritable Bowel Syndrome: From the Bench to the Bedside | Q26769635 | ||
| Role of environmental pollution in irritable bowel syndrome | Q26777544 | ||
| Histamine and histamine-receptor antagonists modify gene expression and biosynthesis of interferon gamma in peripheral human blood mononuclear cells and in CD19-depleted cell subsets | Q28138283 | ||
| Capsaicin receptor: TRPV1 a promiscuous TRP channel | Q28282881 | ||
| The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome | Q28288581 | ||
| Ebastine in allergic rhinitis and chronic idiopathic urticaria | Q28301769 | ||
| Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization | Q28366668 | ||
| Gastric acid secretion in L-histidine decarboxylase-deficient mice | Q28511603 | ||
| A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties | Q28571371 | ||
| Stress-induced visceral hypersensitivity in maternally separated rats can be reversed by peripherally restricted histamine-1-receptor antagonists | Q31119613 | ||
| Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions | Q34094755 | ||
| Inhibitory effects of histamine H4 receptor antagonists on experimental colitis in the rat. | Q34458021 | ||
| FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial | Q34518185 | ||
| Mast cell stabilizer ketotifen [4-(1-methyl-4-piperidylidene)-4h-benzo[4,5]cyclohepta[1,2-b]thiophen-10(9H)-one fumarate] prevents mucosal mast cell hyperplasia and intestinal dysmotility in experimental Trichinella spiralis inflammation in the rat. | Q34567498 | ||
| Review article: serotonin receptors and transporters -- roles in normal and abnormal gastrointestinal motility | Q34650033 | ||
| Acquired cold urticaria symptoms can be safely prevented by ebastine. | Q34694547 | ||
| Trends in histamine research: new functions during immune responses and hematopoiesis | Q34726033 | ||
| Neuropathophysiology of irritable bowel syndrome | Q34787555 | ||
| Immune regulation by histamine | Q34987280 | ||
| Disodium cromoglycate reverses colonic visceral hypersensitivity and influences colonic ion transport in a stress-sensitive rat strain | Q35075865 | ||
| Histamine in the immune regulation of allergic inflammation | Q35171180 | ||
| H1-receptors: localization and role in airway physiology and in immune functions | Q35552822 | ||
| Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. | Q35761348 | ||
| Brain-Gut Interactions in IBS | Q36076024 | ||
| Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome | Q56985161 | ||
| Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome | Q56996391 | ||
| Dose-response relationship of the H1-histamine antagonist, ebastine, against histamine and methacholine-induced bronchoconstriction in patients with asthma | Q68091968 | ||
| Histamine inhibits tumor necrosis factor alpha release by mast cells through H2 and H3 receptors | Q71127308 | ||
| Regulation of ion transport by histamine in human colon | Q71735635 | ||
| Oral cromolyn sodium in comparison with elimination diet in the irritable bowel syndrome, diarrheic type. Multicenter study of 428 patients | Q71767794 | ||
| Role of histamine H(1) receptor in pain perception: a study of the receptor gene knockout mice | Q73556864 | ||
| Histamine sensitivity of mesenteric afferent nerves in the rat jejunum | Q77358779 | ||
| The vanilloid receptor initiates and maintains colonic hypersensitivity induced by neonatal colon irritation in rats | Q79676503 | ||
| Combination of allergic factors can worsen diarrheic irritable bowel syndrome: role of barrier defects and mast cells | Q84964787 | ||
| Histamine antagonism and postinflammatory visceral hypersensitivity | Q87621568 | ||
| Reduced Responses of Submucous Neurons from Irritable Bowel Syndrome Patients to a Cocktail Containing Histamine, Serotonin, TNFα, and Tryptase (IBS-Cocktail) | Q36373974 | ||
| The hypothalamic H1 receptor: a novel therapeutic target for disrupting diurnal feeding rhythm and obesity | Q36439307 | ||
| Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain | Q36930795 | ||
| In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure | Q36979997 | ||
| Functions and imaging of mast cell and neural axis of the gut. | Q37580697 | ||
| Histamine, histamine receptors and their role in immune pathology | Q37677823 | ||
| Quality of life in patients with irritable bowel syndrome | Q37888383 | ||
| Mast cell-nerve axis with a focus on the human gut. | Q37894385 | ||
| Regulation of the immune response and inflammation by histamine and histamine receptors | Q37913659 | ||
| Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis | Q37994513 | ||
| Histamine and gut mucosal immune regulation | Q38167039 | ||
| Histamine H₄ receptors in the gastrointestinal tract. | Q38264340 | ||
| Novel investigational drugs for constipation-predominant irritable bowel syndrome: a review | Q38696256 | ||
| Irritable bowel syndrome and visceral hypersensitivity : risk factors and pathophysiological mechanisms | Q38725315 | ||
| Novel nervous system mechanisms in visceral pain | Q38739236 | ||
| Histamine Receptor H1-Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome | Q39178305 | ||
| Efficacy and tolerability of ebastine 10 mg plus pseudoephedrine 120 mg in the symptomatic relief of the common cold | Q39377696 | ||
| Inhibition of gastric secretion relieves diarrhea and postprandial urgency associated with irritable bowel syndrome or functional diarrhea | Q39436086 | ||
| The role of cyclooxygenase-2 in mediating the effects of histamine on cell proliferation and vascular endothelial growth factor production in colorectal cancer. | Q40366071 | ||
| Comparison of the Rome IV and Rome III criteria for IBS diagnosis: A cross-sectional survey | Q40445611 | ||
| Sensitization of visceral afferents to bradykinin in rat jejunum in vitro | Q42480612 | ||
| Supernatants of irritable bowel syndrome mucosal biopsies impair human colonic smooth muscle contractility. | Q42498868 | ||
| Oral disodium cromoglycate treatment on irritable bowel syndrome: an open study on 101 subjects with diarrheic type | Q42617480 | ||
| Selective expression of histamine receptors H1R, H2R, and H4R, but not H3R, in the human intestinal tract. | Q42844756 | ||
| Treatment of mosquito bites with ebastine: a field trial. | Q42999190 | ||
| Sensitivity testing in irritable bowel syndrome with rectal capsaicin stimulations: role of TRPV1 upregulation and sensitization in visceral hypersensitivity? | Q43420598 | ||
| Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors | Q43749173 | ||
| Neuroimmune interactions in guinea pig stomach and small intestine | Q44185420 | ||
| Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. | Q44779671 | ||
| Histamine-cytokine connection in immunity and hematopoiesis | Q45079615 | ||
| Role of mucosal mast cells in visceral hypersensitivity in a rat model of irritable bowel syndrome. | Q45197721 | ||
| Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life | Q45840782 | ||
| Essential role for TRPV1 in stress-induced (mast cell-dependent) colonic hypersensitivity in maternally separated rats. | Q45971124 | ||
| Endogenous histamine stimulates ischemically sensitive abdominal visceral afferents through H1 receptors. | Q45974300 | ||
| Inflammatory bowel disease versus irritable bowel syndrome: a hospital-based, case-control study of disease impact on quality of life | Q47381227 | ||
| Stress-induced visceral hypersensitivity to rectal distension in rats: role of CRF and mast cells | Q48548051 | ||
| Visceral hypersensitivity in irritable bowel syndrome: evidence for involvement of serotonin metabolism--a preliminary study. | Q50584030 | ||
| Randomised clinical trial: the safety and efficacy of AST-120 in non-constipating irritable bowel syndrome - a double-blind, placebo-controlled study. | Q51419778 | ||
| Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. | Q51660489 | ||
| Involvement of different receptors in the central and peripheral effects of histamine on intestinal motility in the rat. | Q52486402 | ||
| Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome. | Q53622343 | ||
| Histamine receptor 2 modifies dendritic cell responses to microbial ligands. | Q54445895 | ||
| Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. | Q54513905 | ||
| P433 | issue | 3 | |
| P921 | main subject | irritable bowel syndrome | Q838966 |
| P304 | page(s) | 341-348 | |
| P577 | publication date | 2017-05-27 | |
| P1433 | published in | Journal of neurogastroenterology and motility | Q26854010 |
| P1476 | title | Targeting Histamine Receptors in Irritable Bowel Syndrome: A Critical Appraisal | |
| P478 | volume | 23 |
| Q101165858 | Analysis of brain networks and fecal metabolites reveals brain-gut alterations in premenopausal females with irritable bowel syndrome |
| Q57121405 | Blocking H1/H2 histamine receptors inhibits damage/fibrosis in Mdr2 mice and human cholangiocarcinoma tumorigenesis |
| Q57116938 | New treatments and therapeutic targets for IBS and other functional bowel disorders |
Search more.